Doctors at AIIMS, Delhi are developing a low-cost antibody-based adaptive cellular therapy for treatment of multiple myeloma, a form of blood cancer.
Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively.
Scientists have uncovered new details about the mechanism behind cancer progression. Researchers explored the influence the mechanical stiffening of the tumor cell's environment may have on the ...
Researchers have successfully developed a modular synthetic translational coupling element (SynTCE), significantly enhancing ...
For CRISPR Therapeutics specifically, that financial flexibility is not necessarily needed even if it's a plus. As of the most recent quarter, Q3, it reported having around $1.9 billion in cash, ...
FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...
Taking inspiration from the mechanics of WWI aircraft, this innovation could redefine approaches to cancer and heart disease ...
PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. has announced the launch of its Phase 1 clinical trial for VIPER-101, a ...
More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset ...
Hosted on MSN2d
Light-induced gene therapy successfully kills cancer cellsMitochondria, the cell’s energy centers, play a vital role in regulating cellular processes, including growth and survival.
The company is using its Senza5 platform to produce CAR T cells without the CD5 receptor, hoping to enable smaller doses and avoid CAR-T fratricide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback